News
$Lipella Pharmaceuticals (LIPO.US)$ Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform23 MINUTES AGO, 5:00 AM EDTVIA GLOBENEWSWIRE • Patent application covers key technology innovations for delivering therapeutic agents • Proprietary technology enables precise delivery to improve safety and efficacy in oncology, cancer survivorship and immunotherapy • Allowance provides broad IP protection for drug-delivery platform and extends market exclusivity for two lead clinical assets currently in Phase 2 trials
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more4
HannChau : no volume in premarket
Trytosaveabit OP HannChau : Yup! Kinda low